EGFR and non-small cell lung carcinoma: Drug resistance is a multifaceted problem, although the mechanisms of acquired resistance of EGFR‐mutant NSCLC to EGFR‐TKIs have been identified,4 little is known about the transmission of drug resistance between EGFR‐TKI–resistant cells and sensitive cells and this needs to be further elucidated.